Cargando…

Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure

Detalles Bibliográficos
Autores principales:	Veerdonk, FL van de, Kullberg, BJ, Verschueren, IC, Hendriks, T, Meer, JWM van der, Joosten, LAB, Netea, MG
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776203/ http://dx.doi.org/10.1186/cc8086

Ejemplares similares

Caspase-1 and ASC but not NLRP3 mediate antifungal defense in candidiasis sepsis
por: Veerdonk, F van de, et al.
Publicado: (2009)

The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis
por: Ifrim, Daniela C., et al.
Publicado: (2016)

Toll like receptor 1 polymorphisms and susceptibility to invasive candidiasis
por: Plantinga, T, et al.
Publicado: (2009)

Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37
por: van de Veerdonk, Frank L., et al.
Publicado: (2015)

STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis
por: Smeekens, Sanne P., et al.
Publicado: (2011)

IL-1β Processing in Host Defense: Beyond the Inflammasomes
por: Netea, Mihai G., et al.
Publicado: (2010)

Neutrophils are the source of IL-17 and RANKL in zymosan induced arthritis
por: Milanova, Viktoriya I, et al.
Publicado: (2012)

An Exaggerated Monocyte-Derived Cytokine Response to Candida Hyphae in Patients With Recurrent Vulvovaginal Candidiasis
por: Rosati, Diletta, et al.
Publicado: (2020)

Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis
por: Domínguez-Andrés, Jorge, et al.
Publicado: (2017)

Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources
por: Davidson, Linda, et al.
Publicado: (2021)

Patient Susceptibility to Candidiasis—A Potential for Adjunctive Immunotherapy
por: Davidson, Linda, et al.
Publicado: (2018)

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis
por: Rosentul, Diana C., et al.
Publicado: (2014)

Blocking IL-1 to prevent respiratory failure in COVID-19
por: van de Veerdonk, Frank L., et al.
Publicado: (2020)

Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis
por: Pietrella, Donatella, et al.
Publicado: (2011)

Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy
por: Huppler, Anna R, et al.
Publicado: (2012)

New Insights in the Immunobiology of IL-1 Family Members
por: van de Veerdonk, Frank L., et al.
Publicado: (2013)

Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis
por: Delsing, Corine E, et al.
Publicado: (2015)

Signaling through IL-17C/IL-17RE Is Dispensable for Immunity to Systemic, Oral and Cutaneous Candidiasis
por: Conti, Heather R., et al.
Publicado: (2015)

IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
por: Slaats, Jeroen, et al.
Publicado: (2016)

Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis
por: Ling, Yun, et al.
Publicado: (2015)

IL‐17 serum level in patients with chronic mucocutaneous candidiasis disease
por: Chimenz, Roberto, et al.
Publicado: (2022)

In vitro models of hematogenously disseminated candidiasis
por: Filler, Scott G
Publicado: (2014)

Blunted IL-17 responses early after advent of multiple injuries
por: Paraschos, M, et al.
Publicado: (2012)

Inflammasome-Independent Modulation of Cytokine Response by Autophagy in Human Cells
por: Crişan, Tania O., et al.
Publicado: (2011)

The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans
por: Cheng, Shih-Chin, et al.
Publicado: (2011)

Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis
por: Huppler, Anna R., et al.
Publicado: (2015)

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity
por: Okada, Satoshi, et al.
Publicado: (2016)

Neutralizing IL-17 during re-activation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and IL-1
por: Koenders, MI, et al.
Publicado: (2005)

In Vivo Zymosan Treatment Induces IL15-Secreting Macrophages and KLRG1-Expressing NK Cells in Mice
por: Park, Hyun Jung, et al.
Publicado: (2023)

IL-1-dependent cartilage damage in a macrophage-driven arthritis model can be circumvented by T cell IL-17
por: Koenders, MI, et al.
Publicado: (2004)

Genetic susceptibility to Candida infections
por: Smeekens, Sanne P, et al.
Publicado: (2013)

Plasma Levels of IFN-γ, IL-4, IL-6 and IL-17 in HIV-Positive Patients With Oral Candidiasis
por: Ayatollahi Mousavi, Seyyed Amin, et al.
Publicado: (2016)

Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3
por: Oosting, Marije, et al.
Publicado: (2012)

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
por: Puel, Anne, et al.
Publicado: (2010)

Ouabain Modulates Zymosan-Induced Peritonitis in Mice
por: Leite, Jacqueline Alves, et al.
Publicado: (2015)

The mechanism for the radioprotective effects of zymosan‐A in mice
por: Du, Jicong, et al.
Publicado: (2018)

Synthesis, Characterization, and Biological Activity of Aminated Zymosan
por: Venkatachalam, Geetha, et al.
Publicado: (2020)

Characterization of Zymosan-Modulated Neutrophils With Neuroregenerative Properties
por: Jerome, Andrew D., et al.
Publicado: (2022)

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
por: Conti, Heather R., et al.
Publicado: (2009)

Disseminated candidiasis 18 years after renal transplantation
por: Bismay, K., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7285oq9j7s2vtmjlcldlce7c8s